The results showed that CASC9 knockdown apparently suppressed the propagation of CRC cells by inducing cell cycle arrest at the G1 phase and promoting CRC cell apoptosis by activating caspase-9 and caspase-3, which indicated that CASC9 might be an important therapeutic target in CRC. This evidence concerns the gene CASC9 and colorectal carcinoma.